Ilse J. E. Kouijzer
Ilse J. E. Kouijzer has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Wim J. G. Oyen
Department of Radiology and Nuclear Medicine, Rijnstate Hospital, Arnhem, the Netherlands
8 shared publications Chantal P. Bleeker-Rovers
Departments of Internal Medicine and Infectious Diseases
6 shared publicationsFidel J. Vos
Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
4 shared publications- Lioe-Fee de Geus-Oei
Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands
3 shared publications - Arie P. J. van Dijk
Department of Cardiology, Radboud University Medical Centre, Nijmegen, The Netherlands
2 shared publications Marcel J. R. Janssen
Radboud University Nijmegen Medical Centre
2 shared publications
Latest Publications
- 1 August 2018
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 39 (8) , 747-752
18F-fluorodeoxyglucose positron-emission tomography combined with computed tomography as a diagnostic tool in native valve endocarditis
Objective The aim of the study was to investigate the value of 18F-fluorodeoxyglucose positron-emission tomography combined with computed tomography (18F-FDG-PET/CT) in diagnosing native valve endocarditis (NVE). Patients and methods All patients with bacteremia and suspicion of NVE between January 2013 and June 2016 were identified from the hospitals’ register and retrospectively included if echocardiography and 18F-FDG-PET/CT were performed within 14 days. 18F-FDG-PET/CT scans were scored independently by two nuclear medicine physicians. 18F-FDG-PET/CT was compared with the modified-Duke criteria and a multidisciplinary consensus. Results A total of 88 patients were included. In 10 patients with definite NVE according to the modified-Duke criteria, three (30.0%) patients had increased 18F-FDG uptake in or around the heart valves and seven (70.0%) patients had no increased 18F-FDG uptake. In patients without definite NVE according to the modified-Duke criteria, 89.7% (70/78) of the patients had no increased 18F-FDG uptake in or around the heart valves. Of all 20 patients with NVE according to multidisciplinary consensus, nine (45.0%) patients had increased 18F-FDG uptake in or around the heart valves and 11 (55.0%) patients had a normal 18F-FDG-PET/CT result. Conclusion A negative 18F-FDG-PET/CT result should not be interpreted as an exclusion of NVE. In patients with possible or rejected NVE according to the modified-Duke criteria, 18F-FDG-PET/CT could be used in case of sustained suspicion of NVE owing to its high specificity in case of abnormal FDG uptake at the valve region. 18F-FDG-PET/CT is important for detecting metastatic infection which already warrants the need to perform 18F-FDG-PET/CT in all patients with suspected NVE.
- 1 August 2018
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 39 (8) , 747-752
18F-fluorodeoxyglucose positron-emission tomography combined with computed tomography as a diagnostic tool in native valve endocarditis
Objective The aim of the study was to investigate the value of 18F-fluorodeoxyglucose positron-emission tomography combined with computed tomography (18F-FDG-PET/CT) in diagnosing native valve endocarditis (NVE). Patients and methods All patients with bacteremia and suspicion of NVE between January 2013 and June 2016 were identified from the hospitals’ register and retrospectively included if echocardiography and 18F-FDG-PET/CT were performed within 14 days. 18F-FDG-PET/CT scans were scored independently by two nuclear medicine physicians. 18F-FDG-PET/CT was compared with the modified-Duke criteria and a multidisciplinary consensus. Results A total of 88 patients were included. In 10 patients with definite NVE according to the modified-Duke criteria, three (30.0%) patients had increased 18F-FDG uptake in or around the heart valves and seven (70.0%) patients had no increased 18F-FDG uptake. In patients without definite NVE according to the modified-Duke criteria, 89.7% (70/78) of the patients had no increased 18F-FDG uptake in or around the heart valves. Of all 20 patients with NVE according to multidisciplinary consensus, nine (45.0%) patients had increased 18F-FDG uptake in or around the heart valves and 11 (55.0%) patients had a normal 18F-FDG-PET/CT result. Conclusion A negative 18F-FDG-PET/CT result should not be interpreted as an exclusion of NVE. In patients with possible or rejected NVE according to the modified-Duke criteria, 18F-FDG-PET/CT could be used in case of sustained suspicion of NVE owing to its high specificity in case of abnormal FDG uptake at the valve region. 18F-FDG-PET/CT is important for detecting metastatic infection which already warrants the need to perform 18F-FDG-PET/CT in all patients with suspected NVE.
- 1 June 2018
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 18 (6) , 603
Vascular infection with outside-in vertebral destruction in chronic Q fever
- 1 June 2018
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 18 (6) , 603
Vascular infection with outside-in vertebral destruction in chronic Q fever
- 1 June 2018
- Published by Elsevier in Clinical Radiology
- Vol. 73 (6) , 588-589
Diagnostic yield of FDG-PET/CT in fever of unknown origin: a systematic review, meta-analysis, and Delphi exercise
- 1 June 2018
- Published by Elsevier in Clinical Radiology
- Vol. 73 (6) , 588-589
Diagnostic yield of FDG-PET/CT in fever of unknown origin: a systematic review, meta-analysis, and Delphi exercise
- Open Access
- 25 May 2017
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 59 (1) , 127-133
The Value of 18F-FDG PET/CT in Diagnosis and During Follow-up in 273 Patients with Chronic Q Fever
In 1-5% of all acute Q fever infections, chronic Q fever develops, mostly manifesting as endocarditis, infected aneurysms, or infected vascular prostheses. In this study, we investigated the diagnostic value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG-PET/CT) in chronic Q fever at diagnosis and during follow-up. Methods: All Dutch adult patients suspected of chronic Q fever who were diagnosed since 2007 were retrospectively included until March 2015 when at least one 18F-FDG-PET/CT was performed. Clinical data and results from 18F-FDG-PET/CT at diagnosis and during follow-up were collected. 18F-FDG-PET/CT scans were prospectively reevaluated by three nuclear medicine physicians using a structured scoring system. Results: In total, 273 patients with possible, probable, and proven chronic Q fever were included. Of all 18F-FDG-PET/CT scans performed at diagnosis, 13.5% led to a change in diagnosis. Q fever-related mortality rate in patients with and without vascular infection based on 18F-FDG-PET/CT was 23.8% and 2.1%, respectively (P = 0.001). When adding 18F-FDG-PET/CT as a major criterion to the modified Duke criteria, 17 patients (1.9-fold increase) had definite endocarditis. At diagnosis, 19.6% of 18F-FDG-PET/CT led to treatment modification. During follow-up, 57.3% of 18F-FDG-PET/CT resulted in treatment modification. Conclusion: 18F-FDG-PET/CT is a valuable diagnostic technique in diagnosis of chronic Q fever and during follow-up often leading to a change in diagnosis and/or treatment modification, also providing important prognostic information on patient survival.
- 25 May 2017
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 59 (1) , 127-133
Open AccessThe Value of 18F-FDG PET/CT in Diagnosis and During Follow-up in 273 Patients with Chronic Q Fever
In 1-5% of all acute Q fever infections, chronic Q fever develops, mostly manifesting as endocarditis, infected aneurysms, or infected vascular prostheses. In this study, we investigated the diagnostic value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG-PET/CT) in chronic Q fever at diagnosis and during follow-up. Methods: All Dutch adult patients suspected of chronic Q fever who were diagnosed since 2007 were retrospectively included until March 2015 when at least one 18F-FDG-PET/CT was performed. Clinical data and results from 18F-FDG-PET/CT at diagnosis and during follow-up were collected. 18F-FDG-PET/CT scans were prospectively reevaluated by three nuclear medicine physicians using a structured scoring system. Results: In total, 273 patients with possible, probable, and proven chronic Q fever were included. Of all 18F-FDG-PET/CT scans performed at diagnosis, 13.5% led to a change in diagnosis. Q fever-related mortality rate in patients with and without vascular infection based on 18F-FDG-PET/CT was 23.8% and 2.1%, respectively (P = 0.001). When adding 18F-FDG-PET/CT as a major criterion to the modified Duke criteria, 17 patients (1.9-fold increase) had definite endocarditis. At diagnosis, 19.6% of 18F-FDG-PET/CT led to treatment modification. During follow-up, 57.3% of 18F-FDG-PET/CT resulted in treatment modification. Conclusion: 18F-FDG-PET/CT is a valuable diagnostic technique in diagnosis of chronic Q fever and during follow-up often leading to a change in diagnosis and/or treatment modification, also providing important prognostic information on patient survival.
- 1 March 2017
- Published by Edizioni Minerva Medica in The Quarterly Journal of Nuclear Medicine and Molecular Imaging
- Vol. 61 (2) , 232-246
Clinical application of FDG-PET/CT in metastatic infections
Article: Clinical application of FDG-PET/CT in metastatic infections - The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2017 June;61(2):232-46 - Minerva Medica - Journals
- 1 March 2017
- Published by Edizioni Minerva Medica in The Quarterly Journal of Nuclear Medicine and Molecular Imaging
- Vol. 61 (2) , 232-246
Clinical application of FDG-PET/CT in metastatic infections
Article: Clinical application of FDG-PET/CT in metastatic infections - The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2017 June;61(2):232-46 - Minerva Medica - Journals
- Open Access
- 17 June 2016
- Published by Springer Nature in Infection
- Vol. 45 (1) , 41-49
A comparison of the diagnostic value of MRI and 18F-FDG-PET/CT in suspected spondylodiscitis
Purpose The purpose of this study was to evaluate the diagnostic value of 18F-fluorodeoxyglucose (FDG) positron emission tomography and computed tomography (PET/CT scan) and magnetic resonance imaging (MRI) in diagnosing spondylodiscitis and its complications, such as epidural and paraspinal abscesses. Methods From January 2006 to August 2013 patients with a clinical suspicion of spondylodiscitis, with an infection, or with fever of unknown origin were retrospectively included if 18F-FDG-PET/CT and MRI of the spine were performed within a 2-week time span. Imaging results were compared to the final clinical diagnosis and follow-up data were collected. Results Sixty-eight patients were included of whom 49 patients were diagnosed with spondylodiscitis. MRI showed an overall sensitivity of 67 % and specificity of 84 %. Diagnostic accuracy was 58 %, when MRI was performed within 2 weeks after the start of symptoms and improved to 82 %, when performed more than 2 weeks after onset of symptoms. 18F-FDG-PET/CT showed a sensitivity of 96 % and a specificity of 95 %, with no relation to the interval between the scan and the start of symptoms. Conclusions As compared to MRI, 18F-FDG-PET/CT has superior diagnostic value for detecting early spondylodiscitis. After 2 weeks both techniques perform similarly.
- 17 June 2016
- Published by Springer Nature in Infection
- Vol. 45 (1) , 41-49
Open AccessA comparison of the diagnostic value of MRI and 18F-FDG-PET/CT in suspected spondylodiscitis
Purpose The purpose of this study was to evaluate the diagnostic value of 18F-fluorodeoxyglucose (FDG) positron emission tomography and computed tomography (PET/CT scan) and magnetic resonance imaging (MRI) in diagnosing spondylodiscitis and its complications, such as epidural and paraspinal abscesses. Methods From January 2006 to August 2013 patients with a clinical suspicion of spondylodiscitis, with an infection, or with fever of unknown origin were retrospectively included if 18F-FDG-PET/CT and MRI of the spine were performed within a 2-week time span. Imaging results were compared to the final clinical diagnosis and follow-up data were collected. Results Sixty-eight patients were included of whom 49 patients were diagnosed with spondylodiscitis. MRI showed an overall sensitivity of 67 % and specificity of 84 %. Diagnostic accuracy was 58 %, when MRI was performed within 2 weeks after the start of symptoms and improved to 82 %, when performed more than 2 weeks after onset of symptoms. 18F-FDG-PET/CT showed a sensitivity of 96 % and a specificity of 95 %, with no relation to the interval between the scan and the start of symptoms. Conclusions As compared to MRI, 18F-FDG-PET/CT has superior diagnostic value for detecting early spondylodiscitis. After 2 weeks both techniques perform similarly.
- 3 May 2013
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 40 (7) , 1114-5
Reply to comment by Treglia and Bertagna: FDG PET/CT for detection of infectious endocarditis.
- 3 May 2013
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 40 (7) , 1114-5
Reply to comment by Treglia and Bertagna: FDG PET/CT for detection of infectious endocarditis.
- 8 March 2013
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 40 (7) , 1102-1107
The value of 18F-FDG PET/CT in diagnosing infectious endocarditis
Early detection of infectious endocarditis is challenging. For diagnosing infectious endocarditis, the revised Duke criteria are the gold standard. Evidence of endocardial involvement on echocardiography is a major criterion, but sensitivity and specificity of echocardiography are not optimal. Here we investigated the utility of 18F-fluorodeoxyglucose (FDG) positron emission tomography and computed tomography (PET/CT) to diagnose infectious endocarditis in patients with gram-positive bacteraemia.
- 8 March 2013
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 40 (7) , 1102-1107
The value of 18F-FDG PET/CT in diagnosing infectious endocarditis
Early detection of infectious endocarditis is challenging. For diagnosing infectious endocarditis, the revised Duke criteria are the gold standard. Evidence of endocardial involvement on echocardiography is a major criterion, but sensitivity and specificity of echocardiography are not optimal. Here we investigated the utility of 18F-fluorodeoxyglucose (FDG) positron emission tomography and computed tomography (PET/CT) to diagnose infectious endocarditis in patients with gram-positive bacteraemia.